Narrow search
Showing 1 - 10 of 64,617
Cover Image
An empirical model of drug pricing and competition : a dynamic perspective
Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, F. F. H. - In: International journal of economics and business research 6 (2013) 2, pp. 173-193
Persistent link: https://www.econbiz.de/10010351165
Cover Image
The generic drug trilemma
Hemel, Daniel J.; Ouellette, Lisa Larrimore - In: Entrepreneurship and innovation policy and the economy … 2 (2023), pp. 41-77
Persistent link: https://www.econbiz.de/10015049953
Cover Image
International impact of external reference pricing : should national policy-makers care?
Fontrier, Anna-Maria; Gill, Jennifer; Kanavos, Panos - In: The European journal of health economics : HEPAC ; … 20 (2019) 8, pp. 1147-1164
Persistent link: https://www.econbiz.de/10012221319
Cover Image
Value drivers of development stage biopharma companies
Michaeli, Daniel; Yagmur, Hasan Basri; Achmadeev, Timur; … - In: The European journal of health economics 23 (2022) 8, pp. 1287-1296
Persistent link: https://www.econbiz.de/10013407322
Cover Image
Special FDA designations for drug development : orphan, fast track, accelerated approval, priority review, and breakthrough therapy
Michaeli, Daniel; Michaeli, Christoph T.; Albers, Sebastian - In: The European journal of health economics 25 (2024) 6, pp. 979-997
Persistent link: https://www.econbiz.de/10014633366
Cover Image
The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry
Banerjee, Tannista; Siebert, Ralph - 2014
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
Cover Image
Paying off the competition : market power and innovation incentives
Li, Xuelin; Lo, Andrew W.; Thakor, Richard T. - 2021 - This Draft: 19 June 2021
products that are more directly affected by competition. However, at the product therapeutic area level, we find a reduction in … innovation by new entrants after the ruling in response to increased competition. Overall, these results are consistent with …
Persistent link: https://www.econbiz.de/10012818283
Cover Image
Corporate R&D investments following competitors' voluntary disclosures : evidence from the drug development process
Zhang, Yue - In: Journal of accounting research 62 (2024) 1, pp. 335-373
Persistent link: https://www.econbiz.de/10014483578
Cover Image
Pricing and reimbursement of pharmaceuticals in Italy
Folino-Gallo, Pietro; Montilla, Simona; Bruzzone, Mario; … - In: The European Journal of Health Economics 9 (2008) 3, pp. 305-310
Persistent link: https://www.econbiz.de/10005391160
Cover Image
Impact of price control on pharmaceutical sector with reference to India
Kolte, Ashutosh; Mal, Hoshiar; Fulambrikar, Mugdha; … - In: International journal of intelligent enterprise 8 (2021) 1, pp. 90-104
Persistent link: https://www.econbiz.de/10012512495